Show simple item record

dc.contributor.authorTassie, J M
dc.contributor.authorSzumilin, E
dc.contributor.authorCalmy, A
dc.contributor.authorGoemaere, E
dc.date.accessioned2008-02-14T14:44:29Z
dc.date.available2008-02-14T14:44:29Z
dc.date.issued2003-09-05
dc.identifier.citationHighly Active Antiretroviral Therapy in Resource-Poor Settings: The Experience of Médecins Sans Frontières. 2003, 17 (13):1995-7 AIDSen
dc.identifier.issn0269-9370
dc.identifier.pmid12960837
dc.identifier.doi10.1097/01.aids.0000088165.01779.77
dc.identifier.urihttp://hdl.handle.net/10144/18291
dc.description.abstractWe describe the short-term results of highly active antiretroviral therapy (HAART) in seven projects in low and middle income countries. A total of 743 adults were included, and clinical, immunological and virological responses were analysed. At 6 months, outcomes were similar to those observed in western countries, and the probability of remaining on treatment was 94%. The challenge now is to extend access to HAART to the millions in urgent need.
dc.language.isoenen
dc.rightsPublished by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluweren
dc.subject.meshAdolescenten
dc.subject.meshAdulten
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshAntiretroviral Therapy, Highly Activeen
dc.subject.meshDeveloping Countriesen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHumansen
dc.subject.meshMaleen
dc.subject.meshPatient Complianceen
dc.subject.meshTreatment Outcomeen
dc.titleHighly Active Antiretroviral Therapy in Resource-Poor Settings: The Experience of Médecins Sans Frontières.en
dc.contributor.departmentEpicentre, Paris, France.en
dc.identifier.journalAIDS (London, England)en
refterms.dateFOA2019-03-04T09:21:27Z
html.description.abstractWe describe the short-term results of highly active antiretroviral therapy (HAART) in seven projects in low and middle income countries. A total of 743 adults were included, and clinical, immunological and virological responses were analysed. At 6 months, outcomes were similar to those observed in western countries, and the probability of remaining on treatment was 94%. The challenge now is to extend access to HAART to the millions in urgent need.


Files in this item

Thumbnail
Name:
tassie.pdf
Size:
243.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record